Jeff Davidson, Ph.D., professor of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, was honored last month at the joint 27th annual Symposium on Advanced Wound Care and Wound Healing Society meeting in Atlanta for “outstanding lifetime achievement in wound healing.”

A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.

A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies.

A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.”

Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.

Vanderbilt physician/scientist Mary Zutter, M.D., Louise B. McGavock Professor of Pathology, Microbiology and Immunology and assistant vice chancellor for Integrative Diagnostics, can now add “White House guest” to her resume.

A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.